Clinical Trial

The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated November 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study is to learn about the predictive value of targeted next-generation sequencing(tNGS) in pathogen resistance phenotype of patients with lower respiratory tract infection ,by detecting antimicrobial-resistant genes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-15.
Trial Details
NCT Number NCT07035535
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Antimicrobial Drug Resistance, High-Throughput Nucleotide Sequencing
Enrollment 200 participants
Start Date 2023-01-01
Primary Completion 2025-11-28 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-28